Name | bosutinib |
---|---|
Synonyms |
Bosutinib(SKI 606)
3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]- 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile SKI 606 SKI-606 Bosutinib Bosutinib for research Bosutinib (SKI-606) T66 BNJ DCN EMR BG DG EO1& HO1 IO3- AT6N DNTJ D1 |
Description | Bosutinib is a dual Src/Abl inhibitor with IC50s of 1.2 nM and 1 nM, respectively. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 649.7±55.0 °C at 760 mmHg |
Melting Point | 116-120ºC |
Molecular Formula | C26H29Cl2N5O3 |
Molecular Weight | 530.446 |
Flash Point | 346.7±31.5 °C |
Exact Mass | 529.164734 |
PSA | 82.88000 |
LogP | 5.48 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |
Index of Refraction | 1.652 |
Storage condition | room temp |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H319-H413 |
Precautionary Statements | P305 + P351 + P338 |
Hazard Codes | Xi |
Risk Phrases | 36 |
Safety Phrases | 26 |
RIDADR | NONH for all modes of transport |
Precursor 10 | |
---|---|
DownStream 2 | |